Search

Your search keyword '"Euronext Paris S.A. -- Licensing agreements"' showing total 24 results
Start Over Descriptor "Euronext Paris S.A. -- Licensing agreements" Publication Year Range Last 3 years
24 results on '"Euronext Paris S.A. -- Licensing agreements"'

1. Transgene teams up with ProBioGen for individualised cancer vaccines

Subjects
Euronext Paris S.A. -- Licensing agreements, Cancer vaccines -- Licensing agreements, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-November 5, 2024-Transgene teams up with ProBioGen for individualised cancer vaccines (C)2024 M2 COMMUNICATIONS French biotechnology company Transgene (Euronext Paris:TNG) and ProBioGen, a contract development and manufacturing organisation (CDMO) [...]

Published
2024

2. Transgene teams up with ProBioGen for individualised cancer vaccines

Subjects
Euronext Paris S.A. -- Licensing agreements, Cancer vaccines -- Licensing agreements, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-November 5, 2024-Transgene teams up with ProBioGen for individualised cancer vaccines (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk French biotechnology company Transgene (Euronext Paris:TNG) and ProBioGen, a contract development and manufacturing organisation [...]

Published
2024

3. Valneva licenses Shigella vaccine candidate from LimmaTech

Subjects
Valneva SE -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Biological products industry -- Licensing agreements, Biotechnology industry -- Licensing agreements, Vaccines -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-August 1, 2024-Valneva licenses Shigella vaccine candidate from LimmaTech (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Vaccine companies Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and LimmaTech Biologics AG announced on Thursday a strategic [...]

Published
2024

4. Valneva licenses Shigella vaccine candidate from LimmaTech

Subjects
Valneva SE -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Biological products industry -- Licensing agreements, Biotechnology industry -- Licensing agreements, Vaccines -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-August 1, 2024-Valneva licenses Shigella vaccine candidate from LimmaTech (C)2024 M2 COMMUNICATIONS Vaccine companies Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and LimmaTech Biologics AG announced on Thursday a strategic partnership [...]

Published
2024

5. Sanofi and Novavax sign co-exclusive licensing agreement

Subjects
Novavax Inc. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Biotechnology industry -- Licensing agreements, Influenza vaccines -- Licensing agreements, Health care industry -- Licensing agreements, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Health care industry, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-May 10, 2024-Sanofi and Novavax sign co-exclusive licensing agreement (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Novavax Inc (Nasdaq:NVAX) announced [...]

Published
2024

6. Sanofi and Novavax sign co-exclusive licensing agreement

Subjects
Novavax Inc. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Biotechnology industry -- Licensing agreements, Influenza vaccines -- Licensing agreements, Health care industry -- Licensing agreements, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Health care industry, Securities industry, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-May 10, 2024-Sanofi and Novavax sign co-exclusive licensing agreement (C)2024 M2 COMMUNICATIONS French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Novavax Inc (Nasdaq:NVAX) announced on [...]

Published
2024

7. CAFOM Group grants Habitat brand licence to Vente-unique.com

Subjects
Euronext Paris S.A. -- Licensing agreements, Home furnishings industry -- Licensing agreements, Home furnishings -- Licensing agreements, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-April 23, 2024-CAFOM Group grants Habitat brand licence to Vente-unique.com (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk French home furnishings retailer the CAFOM Group (Euronext Paris:CAFO) announced on Tuesday that it has [...]

Published
2024

8. EssilorLuxottica and Michael Kors extend licensing deal

Subjects
Euronext Paris S.A. -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-February 21, 2024-EssilorLuxottica and Michael Kors extend licensing deal (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk EssilorLuxottica SA (Euronext Paris:EL), a French-Italian manufacturer of ophthalmic lenses, frames and sunglasses, and designer brand [...]

Published
2024

9. L'OrA(c)al Groupe enters exclusive licensing agreement with Miu Miu for luxury beauty products

Subjects
Prada S.p.A. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Clothing industry -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-February 9, 2024-L'OrÃ(c)al Groupe enters exclusive licensing agreement with Miu Miu for luxury beauty products (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Beauty company L'Oréal Groupe (Euronext Paris:OR) and Italian luxury fashion [...]

Published
2024

10. Ekinops' SixSq announces updates to the Nuvla platform and marketplace legal framework for improved business enablement

Subjects
Euronext Paris S.A. -- Licensing agreements, Product licensing, Company licensing agreement, Business, News, opinion and commentary
Abstract

PARIS, May 23, 2023 /PRNewswire/ --EKINOPS (Euronext Paris - FR0011466069 -- EKI), a leading network access and virtualization specialist, today announced important updates to the legal framework for the Nuvla [...]

Published
2023

11. Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program

Subjects
Euronext Paris S.A. -- Licensing agreements, Celiac disease, Medical research, Medicine, Experimental, Biological products -- Licensing agreements, Viral antibodies, Antibodies, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, General interest, News, opinion and commentary
Abstract

MARSEILLE: INNATE PHARMA SA has issued the following news release: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) today announced that it has entered into an exclusive license agreement with [...]

Published
2023

12. Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers

Subjects
Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Killer cells, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Securities industry, Company licensing agreement, General interest, News, opinion and commentary
Abstract

MARSEILLE: INNATE PHARMA SA has issued the following news release: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company') announced today the expiration of the waiting period [...]

Published
2023

13. EssilorLuxottica and Roger Federer agree exclusive global eyewear collaboration

Subjects
Euronext Paris S.A. -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-April 27, 2023-EssilorLuxottica and Roger Federer agree exclusive global eyewear collaboration (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk EssilorLuxottica SA (Euronext Paris:EL), a French-Italian manufacturer of ophthalmic lenses, frames and sunglasses, announced [...]

Published
2023

14. Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program

Subjects
Euronext Paris S.A. -- Licensing agreements, Celiac disease, Medical research, Medicine, Experimental, Biological products -- Licensing agreements, Viral antibodies, Antibodies, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Advertising, marketing and public relations
Abstract

2023 APR 22 (VerticalNews) -- By a News Reporter-Staff News Editor at Marketing Weekly News -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced that it has entered into [...]

Published
2023

15. Takeda Licenses Innate Pharma Antibodies for Celiac Disease Research Program

Subjects
Euronext Paris S.A. -- Licensing agreements, Celiac disease, Medical research, Medicine, Experimental, Biological products -- Licensing agreements, Viral antibodies, Antibodies, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Securities industry, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-April 4, 2023-Takeda Licenses Innate Pharma Antibodies for Celiac Disease Research Program (C)2023 M2 COMMUNICATIONS - France-based biotechnology company Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) has entered [...]

Published
2023

16. Innate Pharma receives HSR clearance for expansion of collaboration with Sanofi on NK Cell Engagers

Subjects
Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Health care industry -- Licensing agreements, Killer cells, Health care industry, Company licensing agreement, Chemistry
Abstract

M2 PHARMA-January 25, 2023-Innate Pharma receives HSR clearance for expansion of collaboration with Sanofi on NK Cell Engagers (C)2023 M2 COMMUNICATIONS Innate Pharma SA (Euronext Paris: IPH) (Nasdaq: IPHA), an [...]

Published
2023

17. Innate Pharma receives HSR clearance for expansion of collaboration with Sanofi on NK Cell Engagers

Subjects
Euronext Paris S.A. -- Licensing agreements, Sanofi S.A. -- Licensing agreements, Health care industry -- Licensing agreements, Killer cells, Securities industry -- Licensing agreements, Pharmaceutical industry -- Licensing agreements, Health care industry, Securities industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-January 25, 2023-Innate Pharma receives HSR clearance for expansion of collaboration with Sanofi on NK Cell Engagers (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Innate Pharma SA (Euronext Paris: IPH) (Nasdaq: IPHA), [...]

Published
2023

18. Interparfums signs 15-year fragrance deal with Lacoste

Subjects
Lacoste S.A. -- Licensing agreements, Inter Parfums Inc. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Cosmetics industry -- Licensing agreements, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-December 21, 2022-Interparfums signs 15-year fragrance deal with Lacoste (C)2022 M2 COMMUNICATIONS http://www.m2.com Perfumes and cosmetics manufacturer Inter Parfums Inc (NASDAQ GS:IPAR) announced on Wednesday a new fragrance licence [...]

Published
2022

19. EssilorLuxottica and Ferrari sign expanded licensing deal

Subjects
Ferrari S.p.A. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Automobile industry -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Automobile Industry, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-December 15, 2022-EssilorLuxottica and Ferrari sign expanded licensing deal (C)2022 M2 COMMUNICATIONS http://www.m2.com EssilorLuxottica SA (Euronext Paris:EL), a French-Italian manufacturer of ophthalmic lenses, frames and sunglasses, announced on Thursday [...]

Published
2022

20. Swarovski and EssilorLuxottica sign eyewear licensing deal

Subjects
Euronext Paris S.A. -- Licensing agreements, Eyewear industry -- Licensing agreements, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-December 6, 2022-Swarovski and EssilorLuxottica sign eyewear licensing deal (C)2022 M2 COMMUNICATIONS http://www.m2.com EssilorLuxottica SA (Euronext Paris: EL), a French-Italian manufacturer of ophthalmic lenses, frames and sunglasses, has signed [...]

Published
2022

21. Global Beauty Company Shiseido to Implement Dassault Systemes' Manufacturing Solutions Worldwide as Consumers Push for the Skincare and Wellness

Subjects
Shiseido Company Ltd. -- Licensing agreements, Dassault Systemes S.A. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Toiletries industry -- Licensing agreements, Consumer behavior -- Health aspects, Company licensing agreement, General interest, News, opinion and commentary
Abstract

VELIZY-VILLACOUBLAY: Dassault Systemes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) announced that Shiseido Company, Limited, a 150-year-old global beauty company operating in 120 countries, signed a multiyear licensing agreement to implement Dassault [...]

Published
2022

22. Global Beauty Company Shiseido to Implement Dassault Systemes' Manufacturing Solutions Worldwide as Consumers Push for Skincare and Wellness

Subjects
Shiseido Company Ltd. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Toiletries industry -- Licensing agreements, Consumer behavior -- Health aspects, Cosmetics industry -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, General interest, News, opinion and commentary
Abstract

France: Dassault Systemes SE has issued the following news release: Dassault Systemes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Shiseido Company, Limited, a 150-year-old global beauty company operating in 120 [...]

Published
2022

23. Global Beauty Company Shiseido to Implement Dassault Systemes' Manufacturing Solutions Worldwide as Consumers Push for Skincare and Wellness

Subjects
Shiseido Company Ltd. -- Licensing agreements, Dassault Systemes S.A. -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Computer software industry -- Licensing agreements, Cosmetics industry -- Licensing agreements, Securities industry -- Licensing agreements, Securities industry, Company licensing agreement, Business, Business, international
Abstract

* Shiseido to use Dassault Systemes' 'Perfect Production' industry solution experience to streamline its manufacturing operations management across major production sites * The implementation will support Shiseido's business transformation growth [...]

Published
2022

24. EssilorLuxottica and Armani Group renew eyewear licensing agreement

Subjects
Giorgio Armani Calze -- Licensing agreements, Euronext Paris S.A. -- Licensing agreements, Eyewear industry -- Licensing agreements, Company licensing agreement, Business
Abstract

M2 EQUITYBITES-September 14, 2022-EssilorLuxottica and Armani Group renew eyewear licensing agreement (C)2022 M2 COMMUNICATIONS http://www.m2.com EssilorLuxottica SA (Euronext Paris:EL), a French-Italian manufacturer of ophthalmic lenses, frames and sunglasses, has renewed [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results